Explorer les evidences

6,13 %Hepatitis B was diagnosed in 6.13% of young HIV patients aged 15 to 24 years at a major hospital in Sierra Leone.

Sierra Leonehépatite B · VIH/sidapublié 2023Prevalence and factors associated with advanced HIV disease among young people aged 15 - 2europe_pmcdocument de 8 observationsDOI 10.1101/2023.11.07.23296880

74 testsMean quarterly HBV tests were 74 ± 16 during April–June in Freetown, Sierra Leone.

Sierra Leonehépatite Bobservé April-Junepublié 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument de 8 observationsDOI 10.1101/2023.05.24.23290418

33,4 %The prevalence of hypertension was 33.4% among males and 37.4% among females in Sierra Leone.

Sierra Leonehypertension artériellepublié 2023Sex-and-gender differences in cardiovascular risk factors and their correlates among adulteurope_pmcdocument de 5 observations

80 %Headache was present in 80% of patients with Ebola virus disease at presentation.

Sierra Leonemaladie à virus Ebolapublié 2014The New England journal of medicineeurope_pmcdocument de 14 observations

700 deathsLe nombre de décès liés à l'Ebola en Sierra Leone est passé de près de 700 décès en octobre 2014 à près de 4 000 décès en avril 2015.

Sierra Leonemaladie à virus Ebolaobservé octobre 2014HAL · Unilimdocument de 82 observations

8,2 %The cumulative incidence of surgical site infections (SSIs) was 8.2%.

Sierra Leonesurgical site infections (SSIs)publié 2022Therapeutic advances in infectious diseaseeurope_pmcdocument de 6 observations

11,8 %The prevalence of metabolic syndrome in Freetown, Sierra Leone was 11.8% using the NCEP ATP III criteria among 2,394 selected adults.

Sierra Leonesyndrome métaboliqueobservé 2019 to 2022publié 2023Prevalence and correlates of Metabolic Syndrome among adults in Freetown, Sierra Leone: A europe_pmcDOI 10.1101/2023.06.26.23291915

38,4 %Of the 1369 people diagnosed with HIV, 526 (38.4%) were linked to care.

Sierra LeoneVIH/sidapublié 2024AIDS and behavioreurope_pmcdocument de 7 observations

55 257 dosesThe median monthly uptake of total IPTp was 55,257 during COVID-19.

Sierra Leonepaludismepublié 2025Impact of the COVID-19 pandemic on the uptake of intermittent sulphadoxine-pyrimethamine feurope_pmcdocument de 5 observations

27 %HBV screening increased by 27% in the first year after COVID-19 in Freetown, Sierra Leone.

Sierra Leonehépatite Bpublié 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument de 8 observationsDOI 10.1101/2023.05.24.23290418

7,34 aORTuberculosis independently predicted diabetes/prediabetes among people living with HIV, with an adjusted odds ratio of 7.34.

Sierra Leonediabetes/prediabetes · tuberculosepublié 2022Journal of clinical medicineeurope_pmcdocument de 9 observations

31,2 %C-reactive protein was elevated in 31.2% of the articles on COVID-19 patients with sepsis or septic shock.

Sierra LeoneCOVID-19 · sepsis · septic shockpublié 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument de 17 observationsDOI 10.21203/rs.3.rs-30474/v1

95,2 %The largest reduction in HIV testing in 2020 occurred among children under 15, with a 95.2% decrease.

Sierra LeoneVIH/sidaobservé 2020publié 2024AIDS and behavioreurope_pmcdocument de 7 observations

3,8 %Among 23 patients with chronic pulmonary aspergillosis (CPA), 2 (3.8%) had current TB and 18 (17.3%) had past TB.

Sierra Leonepulmonary aspergillosis · tuberculoseobservé November 2021 to July 2022publié 2023PLoS neglected tropical diseaseseurope_pmcdocument de 9 observations

60 %Dizziness was present in 60% of patients with Ebola virus disease at presentation.

Sierra Leonemaladie à virus Ebolapublié 2014The New England journal of medicineeurope_pmcdocument de 14 observations

72,2 %Among 306 adult participants in Freetown, Sierra Leone, 72.2% stated they would receive the HBV vaccine if offered.

Sierra Leonehépatite Bpublié 2023Healthcare (Basel, Switzerland)europe_pmcdocument de 5 observationsDOI 10.3390/healthcare11020177

58 %Among suspected COVID-19 patients, 58% of the antibiotics prescribed belonged to the 'WATCH' category.

Sierra LeoneCOVID-19publié 2022International journal of environmental research and public healtheurope_pmcdocument de 3 observationsDOI 10.3390/ijerph19074005

5,4 %The lowest mortality among study participants with COVID-19 and sepsis or septic shock was 5.4%.

Sierra LeoneCOVID-19 · sepsis · septic shockpublié 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument de 17 observationsDOI 10.21203/rs.3.rs-30474/v1

5,9 %Among pregnant women in Sierra Leone, Y181C/V/I was found in 5.9% (n = 2/34) of cases.

Sierra LeoneVIH/sidapublié 2021Geneseurope_pmcdocument de 21 observationsDOI 10.3390/genes12091314

2 timesThe true epidemic size of mpox in Sierra Leone was estimated to be nearly double the official case counts.

Sierra Leonempoxpublié 2026Nature medicineeurope_pmcdocument de 4 observations

Childhood vaccination coverage against hepatitis B virus is suboptimal in Sierra Leone, Liberia, and Guinea.

Guinée · Liberia · Sierra Leonehépatite Bpublié 2023Epidemiology and infectioneurope_pmcdocument de 3 observationsDOI 10.1017/s0950268823001735

5 000 casesSierra Leone had more than 5,000 confirmed mpox cases by August 2025.

Sierra Leonempoxobservé Augustpublié 2026Nature medicineeurope_pmcdocument de 4 observations

68,5 %The proportion of drug-resistant TB cases that completed treatment was 68.5% in the post-COVID-19 period.

Sierra Leonedrug-resistant TBobservé post-COVID-19publié 2025Effect of the COVID-19 pandemic on drug-resistant tuberculosis treatment outcomes at a nateurope_pmcdocument de 9 observations

51 %Diarrhea was present in 51% of patients with Ebola virus disease at presentation.

Sierra Leonemaladie à virus Ebolapublié 2014The New England journal of medicineeurope_pmcdocument de 14 observations

36,1 %Only 753 (36.1%) HIV-positive women had documented facility-based delivery.

Sierra LeoneVIH/sidapublié 2026PLOS global public healtheurope_pmcdocument de 6 observations